BPI 2026 · CDMO & CRO
FUJIFILM Biotechnologies at BPI 2026
FUJIFILM Biotechnologies brings 3 presentations to BPI 2026 in Boston, and exhibits at Booth 1030. Its program addresses CMC questions for antibodies and newer therapies. Sessions cover processing and formulating high-concentration monoclonal antibodies, establishing the limit of in vitro cell age for a manufacturing process, and choosing between platform and bespoke purification.
| Organization | BPI 2026 Attendance |
|---|---|
1 Senior Principal Scientist, Process Development · 1 Director of Upstream Process Development · 1 Senior Director of Downstream Process Development | |
Contract development and manufacturing organization for biologics, vaccines and advanced therapies, formerly FUJIFILM Diosynth Biotechnologies, with sites in the US, UK, Denmark and Japan. | Booth Exhibiting at Booth 1030 Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm Talk Wed Sep 23 3:00pm–3:30pm Talk Thu Sep 24 2:45pm–3:15pm |
Instantly find 20 buyers from FUJIFILM Biotechnologies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction